Tectonic Therapeutic (TECX) Operating Expenses (2017 - 2026)

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Tectonic Therapeutic was $94.93 million, up 27.8% year-over-year; for FY2025, it was $84.04 million, up 44.9% from FY2024.

• Annual Operating Expenses shows a five-year compound annual growth rate of -6.9% (FY2020 to FY2025).
• In prior years, Tectonic Therapeutic's Operating Expenses was $58.02 million in FY2024 (+29.9%), $44.65 million in FY2023 (-57.7%), $105.43 million in FY2022 (-11.3%) and $118.84 million in FY2021 (-1.2%).
• Quarterly Operating Expenses has run from a low of $9.37 million in Q4 2023 to a high of $32.62 million in Q3 2021 over five years.
• On a year-over-year basis, Operating Expenses has increased in each of the last nine quarters, with growth averaging 50.4% over the last eight quarters.
• The strongest year-over-year quarter for Operating Expenses in the past five years was Q2 2025, with growth of 95.5%; the weakest was Q4 2023, with a decline of 62.9%.
• According to Business Quant data, Operating Expenses for the three prior quarters was $27.3 million (Q1 2026), $21.52 million (Q4 2025) and $21.89 million (Q3 2025).